NASDAQ:JAZZ | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Jazz Pharmaceuticals Raises $850 Million in Convertible Debt Offering, Signaling Financial Strategy Shift

Business

3 Sep, 2024

Jazz Pharmaceuticals Raises $850 Million in Convertible Debt Offering, Signaling Financial Strategy Shift


Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has taken a significant step in its financial strategy, announcing a private offering of $850...

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences: Key Dates and What to Expect

Business

23 Aug, 2024

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences: Key Dates and What to Expect


Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced its participation in two upcoming investor conferences in September 2024. The company will...

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences

Business

22 Aug, 2024

Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences


Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has announced its participation in two upcoming investor conferences in September 2024. The company will...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates